Accounts Payable

$30.40M

Quarterly · Period ending: Jun 30, 2026 · USD

MYGN Accounts Payable

Latest reported$30.40Mperiod endingJun 30, 2026

MYGN Quarterly Accounts Payable ($1.90M → $30.40M)

Quarterly accounts payable

High-resolution chart · PNG

MYGN accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Accounts Payable — Quarterly (USD)
Period ending	Accounts Payable (USD)
Jun 30, 2026	30,400,000
Mar 31, 2026	32,600,000
Dec 31, 2025	30,000,000
Sep 30, 2025	31,800,000
Jun 30, 2025	30,900,000
Mar 31, 2025	28,100,000
Dec 31, 2024	32,300,000
Sep 30, 2024	29,600,000
Jun 30, 2024	33,300,000
Mar 31, 2024	33,100,000
Dec 31, 2023	25,800,000
Sep 30, 2023	33,900,000
Jun 30, 2023	39,800,000
Mar 31, 2023	36,500,000
Dec 31, 2022	28,800,000
Sep 30, 2022	29,600,000
Jun 30, 2022	21,700,000
Mar 31, 2022	27,100,000
Dec 31, 2021	29,600,000
Sep 30, 2021	15,700,000
Jun 30, 2021	28,500,000
Mar 31, 2021	20,800,000
Dec 31, 2020	20,500,000
Sep 30, 2020	19,100,000
Jun 30, 2020	21,700,000
Mar 31, 2020	30,300,000
Dec 31, 2019	21,000,000
Sep 30, 2019	24,000,000
Jun 30, 2019	33,300,000
Mar 31, 2019	24,100,000
Dec 31, 2018	31,900,000
Sep 30, 2018	23,800,000
Jun 30, 2018	26,000,000
Mar 31, 2018	20,200,000
Dec 31, 2017	25,100,000
Sep 30, 2017	22,500,000
Jun 30, 2017	22,000,000
Mar 31, 2017	26,800,000
Dec 31, 2016	22,900,000
Sep 30, 2016	19,900,000
Jun 30, 2016	21,100,000
Mar 31, 2016	13,800,000
Dec 31, 2015	16,500,000
Sep 30, 2015	15,800,000
Jun 30, 2015	21,100,000
Mar 31, 2015	17,955,000
Dec 31, 2014	16,833,000
Sep 30, 2014	25,728,000
Jun 30, 2014	23,100,000
Mar 31, 2014	18,935,000
Dec 31, 2013	17,596,000
Sep 30, 2013	18,745,000
Jun 30, 2013	18,132,000
Mar 31, 2013	12,238,000
Dec 31, 2012	13,575,000
Sep 30, 2012	11,086,000
Jun 30, 2012	10,141,000
Mar 31, 2012	7,939,000
Dec 31, 2011	8,876,000
Sep 30, 2011	9,827,000
Jun 30, 2011	11,395,000
Mar 31, 2011	5,191,000
Dec 31, 2010	7,050,000
Sep 30, 2010	7,242,000
Jun 30, 2010	8,870,000
Mar 31, 2010	7,026,000
Dec 31, 2009	9,403,000
Sep 30, 2009	7,648,000
Jun 30, 2009	14,177,000
Mar 31, 2009	11,426,000
Dec 31, 2008	12,771,000
Sep 30, 2008	14,999,000
Jun 30, 2008	24,884,000
Mar 31, 2008	12,009,000
Dec 31, 2007	13,910,000
Sep 30, 2007	13,993,000
Jun 30, 2007	15,763,000
Mar 31, 2007	10,998,000
Dec 31, 2006	15,197,000
Sep 30, 2006	11,650,000
Jun 30, 2006	11,804,000
Mar 31, 2006	10,492,000
Dec 31, 2005	14,708,000
Sep 30, 2005	9,720,000
Jun 30, 2005	11,897,000
Mar 31, 2005	7,899,000
Dec 31, 2004	8,309,000
Sep 30, 2004	6,601,000
Jun 30, 2004	7,938,000
Mar 31, 2004	8,927,000
Dec 31, 2003	3,890,000
Sep 30, 2003	5,809,000
Jun 30, 2003	11,454,000
Mar 31, 2003	4,653,000
Dec 31, 2002	11,609,000
Sep 30, 2002	5,862,000
Jun 30, 2002	9,461,575
Mar 31, 2002	5,306,775
Dec 31, 2001	6,743,148
Sep 30, 2001	5,703,250